FTC sues to block Amgen acquisition of Horizon TherapeuticsAmgen wants to buy Horizon Therapeutics to bolster is drug portfolio as it faces patent expirations. The FTC fears the deal could entrench monopoly positions.[Collection]

Amgen wants to buy Horizon Therapeutics to bolster is drug portfolio as it faces patent expirations. The FTC fears the deal could entrench monopoly positions.https://www.cnbc.com/2023/05/16/horizon-therapeutics-amgen-deal-ftc.html